Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model — Aristotelis Bamias (2010) | RDL Network
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model
Article 2010 en
Authors
AB
Aristotelis Bamias
AK
Alexandra Karadimou
SL
Sofia Lampaki
Abstract
1 min read
Studies on risk stratification of patients with advanced RCC treated with targeted therapies are warranted. Our results suggest that a simpler than the MSKCC model can be developed. Such models should be further validated.
Vasilios Karavasilis, Kimon Tzanis, Christina Bamia, Réza‐Thierry Elaidi, Efthimios Kostouros, Antonios Visvikis, D. Skarlos, Helena Linardou, E. Razis, Michael Chrisofos, Konstantinos Stravodimos, George Lazaridis, Eleni Timotheadou, C. Hatzimouratidis, Stéphane Oudard, George Fountzilas, Meletios A Dimopoulos, Aristotelis Bamias
Aristotelis Bamias, Kimon Tzannis, Benoit Beuselinck, Stéphane Oudard, Bernard Escudier, D Diosynopoulos, Kostas Papazisis, H. Lang, Pascal Wolter, Éléonore De Guillebon, Konstantinos Stravodimos, Michael Chrisofos, George Fountzilas, R-T. Elaidi, Meletios A Dimopoulos, Christina Bamia
Rasmus Mikiver, Roger Olofsson Bagge, Michael A. Marchetti, Alexander Christopher Jonathan Van Akkooi, Daniel G. Coit, Christian Ingvar, Karolin Isaksson, Richard A Scolyer, John F. Thompson, Alexander H. R. Varey, Johan Lyth, Edmund K. Bartlett
Nicolas M. Van Mieghem, Stuart J. Head, Robert van der Boon, Nicolò Piazza, Peter P. de Jaegere, Thierry Carrel, A. Pieter Kappetein, Rüediger Lange, Thomas Walther, Stephan Windecker, Gerrit‐Anne van Es, Patrick W. Serruys
Discussion(0)
No comments yet. Be the first to comment.